Gaize, Inc., on the 17th of November, 2022, announced the completion of the world’s most extensive clinical research investigating cannabis impairment. Gaize’s portable, non-invasive testing apparatus was employed in the 350-person study to assess pupillary reflex and eye movement response alterations.
The Trump administration is preparing to move cannabis from Schedule I to Schedule III of…
Based on the ruling, products that are legal federally as well as at the state…
The drug’s history of healing and experimentation stretches from ancient China to American counterculture —…
The new partnership will spotlight the stories of people still behind bars for cannabis, support…
Colombia is moving forward with a controversial plan to euthanize dozens of invasive hippos descended…
Imported hashish sustained mountain economies for centuries—until modern legalization and market economics erased it almost…